<html><body><h2>Case: 2561485</h2><h3> CDS Time: 1959-09-22</h3>
<patient name=2561485>
59.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">59</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">51</td><td width="200">1959-5-12</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">51</td><td width="200">1959-5-12</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">227</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">6</td><td width="200">1959-8-29</td></tr>
<tr><td width="200">Chloride</td><td width="200">99.0</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">65</td><td width="200">1959-9-9</td></tr>
<tr><td width="200">Weight</td><td width="200">284</td><td width="200">1959-9-9</td></tr>
<tr><td width="200">HbA1C</td><td width="200">4</td><td width="200">1959-8-6</td></tr>
<tr><td width="200">SGOT</td><td width="200">140</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">133</td><td width="200">1959-8-27</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">114</td><td width="200">1959-9-9</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">2</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Height</td><td width="200">70</td><td width="200">1959-9-9</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">133</td><td width="200">1959-8-27</td></tr>
<tr><td width="200">BUN</td><td width="200">37</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">HCT</td><td width="200">25</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">HGB</td><td width="200">8</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Sodium</td><td width="200">134</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Albumen</td><td width="200">2</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Creatinine</td><td width="200">4.1</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">4</td><td width="200">1959-8-6</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">51.0</td><td width="200">1959-5-12</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">51</td><td width="200">1959-5-12</td></tr>
<tr><td width="200">Pulse</td><td width="200">92</td><td width="200">1959-9-9</td></tr>
<tr><td width="200">PLT</td><td width="200">78</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">WBC</td><td width="200">15</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">SGPT</td><td width="200">262</td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Creatinine_Clearance</td><td width="200">N/A</td><td width="200">1959-5-14</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Renovascular_Disease</td><td width="200"></td><td width="200">1959-9-12</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1959-9-22</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1959-9-22</td></tr>
<tr><td width="200">nausea</td><td width="200"></td><td width="200">1959-8-29</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1959-8-7</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1959-9-19</td></tr>
<tr><td width="200">liver</td><td width="200"></td><td width="200">1959-9-22</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1959-9-2</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1959-9-19</td></tr>
<tr><td width="200">complications of transplant</td><td width="200"></td><td width="200">1959-9-13</td></tr>
<tr><td width="200">diarrhea</td><td width="200"></td><td width="200">1959-8-29</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1959-8-9</td></tr>
<tr><td width="200">Atrial_Tachycardia</td><td width="200"></td><td width="200">1959-9-18</td></tr>
</table>
<p><b>Medications:</b> tacrolimus(1.0) spironolactone(400.0) furosemide(40.0) Insulin(0.04) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Transplant recipients</td>
<td width="200">1959-09-22</td>
<td width="200"> liver()</td></tr>
<tr> <td width="200"></td>
<td width="200">1959-09-13</td>
<td width="200"> complications of transplant()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(134.0/1959-9-22)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(4.1/1959-9-22)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">MI (secondary prevention) BP controlled</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction (Secondary Prevention)[Treatment_Diastolic_BP(65/null) && Treatment_Systolic_BP(114/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[presence of CKD (icd9 codes)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.0/1959-9-22) && presence of MI]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">MI no HF</td>
<td width="200"></td>
<td width="200"> MI no HF[Absence of HF && Presence of MI]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">High Risk for HF and DM, HTN, or atherosclerotic vascular disease</td>
<td width="200"></td>
<td width="200"> High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]()</td></tr>
<tr><td width="200">Male and most recent creatinine>2.5</td>
<td width="200"></td>
<td width="200"> Male and most recent creatinine>2.5[Sex(Male) && Creatinine(4.1/1959-9-22)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1959-09-12</td>
<td width="200"> Renovascular_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200">1959-08-09</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1959-09-22</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1959-09-22</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1959-09-19</td>
<td width="200"> Liver_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGOT(140.0/1959-9-22)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1959-08-07</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1959-09-18</td>
<td width="200"> Atrial_Tachycardia()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.0/1959-9-22) && presence of MI]()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.0/1959-9-22) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1959-08-29</td>
<td width="200"> diarrhea()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1959-09-19</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200">1959-05-14</td>
<td width="200"> Creatinine_Clearance()
<tr> <td width="200"></td>
<td width="200">1959-09-02</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200">1959-08-29</td>
<td width="200"> nausea()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage B HF
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(65/null) && Treatment_Systolic_BP(114/null))
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> unknown(LDL_Cholesterol(no value))
<p><b>Messages by Types</b>
<ul>
<li><b>Class I</b>
<ul>
<li>Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li>Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li>Ventricular rate should be controlled or sinus rhythm restored in
patients with supraventricular tachyarrhythmias who are at high
risk for developing HF. (Level of Evidence: B)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage A messages</b><br>
<ul>
<li><b>behavior control <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li><b>Periodic evaluation <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li><b>Ventricular rate/sinus rhythm  control <font color=FF0000>preferred</font></b>(rule in criterion<i> Presence of supraventricular tachyarrhythmias</i> evaluate to <b> true</b> because <i>Presence of supraventricular tachyarrhythmias</i>)])
Ventricular rate should be controlled or sinus rhythm restored in
patients with supraventricular tachyarrhythmias who are at high
risk for developing HF. (Level of Evidence: B)
<li><b>not use nutritional supplements <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
<li><b>Secondary prevention</b><br>
<ul>
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>Ace_Inhibitor(Captopril, Lisinopril)<ul><li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction) </font><li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]) <li>rec add ace: dose adjustent based on kidney functio(Refer to specific ACE Inhibitor dose adjustments based on kidney function.)<li>monitoring renal function and K(Need to find content)<li>preference: preferred</ul><li>Beta blocker stage B post MI(Carvedilol)<ul><li><font color=FF0000>Compelling indications:  MI no HF(MI no HF[Absence of HF && Presence of MI]) </font><li>preference: preferred</ul><li>ARB<ul><li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]) <li>preference: preferred</ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Beta Blocker Stage B no MI<ul><li>preference: neutral<li>No comment</ul><li>NDHP CCB<ul><li>Contraindications:  Myocardial_Infarction(Myocardial_Infarction) <li>preference: ruled out</ul></ul></body></html>